ATAGI have published recommendations for the influenza vaccine program in 2021. This advice includes vaccine brand and dose information, the timing of administration, funding eligibility criteria as well as the requirement for reporting all vaccine administration to the 澳大利亚免疫登记 (AIR).
To view the recommendations please follow the link below: